Core Scientific director Levy Jordan buys $500,506 in common stock

Published 07/03/2025, 00:48
Core Scientific director Levy Jordan buys $500,506 in common stock

Levy Jordan, a director at Core Scientific, Inc. (NASDAQ:CORZ), has made a significant purchase of the company’s common stock amid the company’s recent 26.7% decline over the past week. According to a recent SEC filing, Jordan acquired 62,500 shares on March 6, 2025, at a weighted average price of $8.0081 per share. This transaction, which totals approximately $500,506, reflects a range of prices from $7.995 to $8.02 per share. InvestingPro analysis suggests the stock is currently in oversold territory, with analyst price targets ranging from $17 to $24.

Following this acquisition, Jordan now holds a total of 306,887 shares directly in Core Scientific. This move comes as part of his ongoing involvement with the company, which operates in the finance services sector, focusing on crypto assets. With a market capitalization of $2.82 billion and a strong current ratio of 6.72, InvestingPro data shows the company maintains solid liquidity despite recent market volatility. For deeper insights into CORZ’s valuation and future prospects, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.

In other recent news, Core Scientific Inc . reported a challenging fourth quarter of 2024 with a 33% year-over-year decrease in total revenue to $94.9 million, and a widened net loss of $265 million compared to the previous year. The company mined significantly fewer Bitcoins, with output dropping from 3,042 in the previous year to just 9.74 in Q4 2024. Despite these setbacks, Core Scientific managed to reduce its debt by $270 million through Chapter 11 restructuring and ended the year with over $830 million in cash. Cantor Fitzgerald analyst Brett Knoblauch adjusted the company’s price target to $20.00 from $21.00, citing the recent decrease in Bitcoin mining productivity, while maintaining an Overweight rating. Additionally, Core Scientific appointed Jim Nygaard as the new Chief Financial Officer, bringing extensive experience in mergers and acquisitions. The company is expanding its operations to support AI-related workloads, with new developments in its data centers across the United States. These changes reflect Core Scientific’s efforts to diversify its portfolio and enhance its infrastructure capabilities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.